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Sheeva Mostoufi1,2, Kathryn M Godfrey1,2, Sandra M Ahumada3, Nazia Hossain2, Titus Song4, Lisa Johnson Wright5,
James B Lohr2,4 and Niloofar Afari2,4*Abstract
Background: Despite substantial research on the comorbidity of anxiety disorders including posttraumatic stress
disorder (PTSD) and chronic pain, little is known about the mechanisms underlying these conditions that might be
potentially similar. Evoked pain sensitivity is one factor that has been associated with several pain conditions which
might also have relevance to anxiety disorders and PTSD. The aim of this preliminary study was to examine evoked
pain sensitivity in PTSD compared to other anxiety disorders and in control participants.
Method: The study used a cross-sectional case-control design in which participants completed a battery of
questionnaires and structured interview and underwent cold pressor testing.
Results: Of 61 total participants, those in the PTSD (n =16) and other anxiety groups (n =12) endorsed significantly
higher levels of psychological symptoms and poorer health functioning than control participants (n =33). The linear
trend across baseline, threshold, and tolerance pain ratings from the cold pressor task significantly differed between
participants with PTSD and the other anxiety and control groups suggesting lower pain sensitivity to a standardized
stimulus of pain in individuals with PTSD.
Conclusions: These findings are similar to some of the prior research and suggest that individuals with PTSD may
exhibit lower cold pain sensitivity compared to those with other anxiety disorders. There is a need for future research
to determine explanatory mechanisms.
Keywords: PTSD, Anxiety, Pain sensitivity, Chronic pain, ComorbidityBackground
A substantial body of literature has documented that anx-
iety disorders such as posttraumatic stress disorder (PTSD)
and chronic pain often occur concurrently [1-5]. An esti-
mated 11–60% of patients with chronic pain report the
co-occurrence of various anxiety disorders [6]. Individuals
with PTSD and chronic pain report higher ratings of psy-
chiatric distress, greater disability, and more intense pain
compared to those with PTSD or chronic pain only [7-9].
Despite substantial research on this comorbidity, little is* Correspondence: nafari@ucsd.edu
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unless otherwise stated.known about the mechanisms underlying these conditions
that might be potentially similar across anxiety disorders
including PTSD and chronic pain. Evoked pain sensitivity
is one factor that has been associated with several pain
conditions and extensively examined in the pain literature
[10,11], which may also have relevance to anxiety disorders
and PTSD.
Evoked pain sensitivity is generally described in terms
of pain threshold, which is the lowest stimulus inten-
sity of pain that is detected by an individual, and pain
tolerance, which is the maximum pain intensity one is
willing to stand. Increased pain sensitivity is typically con-
ceptualized along both perceptual (i.e., higher pain ratings)
and behavioral (i.e., lower time to tolerance) domains, with
both sets of measurements reflecting independent indica-
tors yet complementary information on one’s sensitivity toal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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patients with fibromyalgia [11] and low back pain [10],
for example, have found increased sensitivity to painful
stimuli as measured in both perceptual and behavioral
domains. Further, increased pain sensitivity has been linked
to a higher incidence of temporomandibular pain disorders
in a prospective cohort study [14]. Although the literature
is largely cross-sectional, making it difficult to determine
whether increased pain sensitivity precedes or follows
chronic pain, these findings suggest that greater sensitivity
to painful stimuli may play a role in the development and
maintenance of chronic pain.
There is a small body of literature examining pain sen-
sitivity in PTSD and other anxiety disorders. Interestingly,
despite the substantial comorbidity of PTSD with chronic
pain conditions, individuals with PTSD have been found to
endorse “hyposensitivity” or lowered perception of pain in
evoked pain paradigms [15-17]. However, the one study that
compared patients with PTSD to other anxiety disorders
had mixed results, perhaps because individuals with chronic
pain were not excluded [18]. While individuals with PTSD
(n =32) were found to rate painful stimuli as more intense
than other anxiety (n =29) and control (n =20) groups sug-
gesting increased pain sensitivity on the perceptual indica-
tors, they exhibited higher thresholds and, therefore, lowered
sensitivity on the behavioral indicators of pain [18]. Thus,
there is some reason to believe that individuals with PTSD
may have altered pain sensitivity compared to both healthy
individuals and those with other anxiety disorders. However,
given the known association of chronic pain with increased
pain sensitivity [10,11,14], it is difficult to interpret these find-
ings in the context of the handful of other studies that have
examined PTSD without pain [15-17], in order to better
understand the direct link between pain sensitivity and PTSD.
In addition to the issue of examining pain sensitivity in
PTSD with and without chronic pain, the handful of stud-
ies on PTSD and pain sensitivity were limited by the use
of primarily veteran and male samples with only one type
of trauma (i.e., combat) and having participants drawn
from a clinical population [15,16,18]. Therefore, the goals
of this preliminary study were to address some of the pre-
vious limitations by examining the following: 1) examine
cold pressor pain ratings at baseline, threshold and toler-
ance (i.e., perceptual indicators) for community male and
female participants with PTSD but without chronic pain
compared with participants with other anxiety disorders,
and non-anxious controls; and 2) examine time from cold
pain threshold to tolerance (i.e., behavioral indicator) for
the three groups of participants.
Methods
Participants and procedures
Participants with PTSD, with other anxiety disorders,
and healthy controls were recruited through flyers andadvertisements in the community, physician contacts, and
mental health clinics at the Veteran’s Affairs San Diego
Healthcare System (VASDHS) and the University of
California, San Diego. Potential participants were screened
on the telephone to assess initial eligibility (i.e., PTSD,
other anxiety disorders, healthy control). Exclusion criteria
for all groups were as follows: 1) serious or unstable med-
ical illnesses (e.g., cancer, kidney failure, stroke, cardiovas-
cular disease, seizure, etc.); 2) physical impairments (e.g.,
blindness, deafness); 3) schizophrenia or other psychotic
disorders; 4) current alcohol abuse or dependence as
assessed by the Alcohol Use Disorders Identification Test
(AUDIT-C) [19]; 5) current drug abuse or dependence
through detailed questions; 6) a history of negative reac-
tions to cold temperatures or any conditions such as
Raynaud’s disease, temperature-induced urticaria, or other
conditions that are exacerbated or influenced by cold
temperatures; and 7) a history of chronic pain lasting
for more than 6 months based on the Wall and Mezlack’s
(1999) [20] definition which considers chronic pain to last
6 months, be ongoing, and not due to life threatening
causes. All participants who met the above inclusion and
exclusion criteria were invited to participate. For the ana-
lyses presented here, we took an additional conservative
step by excluding all individuals reporting any pain lasting
1–5 months from the reported analyses rendering our
final sample free of any pain other than sporadic pain
of less than 1 month duration (e.g., occasional headache,
menstrual cramps, etc.). Participants who were determined
to be initially eligible based on the telephone screen
attended an on-site study visit, where they took part in
a cold pressor task and completed a battery of question-
naires. Participants subsequently underwent a structured
psychiatric interview. Participants agreed not to take any
pain medications for 12 hours prior to the on-site study
visit.
Of the 267 individuals who were contacted for a tele-
phone screen, 145 were initially eligible and 120 came in
for the lab study and underwent the structured psychiatric
interview. Since participants were primarily recruited from
the community, their initial enrollment into the study was
based on their self-report of symptoms and diagnoses.
Once the structured psychiatric interview was completed,
there were 59 individuals who did not clearly fit into the
diagnostic categories based on our strict inclusion criteria
for group placement (e.g., self-reported a diagnosis of
PTSD but were not positive for PTSD based on the
interview, etc.). Thus, 61 of the 120 met the criteria for
PTSD, another anxiety disorder, or were controls, and
all of the other inclusion and exclusion criteria to be in-
cluded in these analyses. The study was approved by the
Institutional Review Board of the University of California,
San Diego, and the VASDHS Research and Development
Committee. Written informed consent was obtained from
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completing the structured interview and $30 for their time
at the study visit. All authors had access to the data.
Measures
Demographics
Demographic information including age, gender, marital
status, education, income, and race/ethnicity were obtained
as part of the initial telephone screening.
Structured psychiatric interview
Participants were administered the PTSD and anxiety
disorders modules of the Composite International Diag-
nostic Interview (CIDI), a structured and lay administered
telephone psychiatric interview that assesses for current
and historic diagnoses as established in the ICD-10 and
DSM-IV [21]. The interview was administered by bachelor
level assessors who were trained to administer the inter-
view reliably with other assessors and were supervised by
a licensed clinical psychologist, who reviewed the results
of each interview. The CIDI is a widely used diagnostic
interview in population-based samples and has accept-
able reliability and validity in community studies [22,23],
and was used to confirm diagnosis and group placement.
Individuals who had a primary diagnosis of PTSD based
on the DSM-IV criteria were placed in the PTSD group.
Individuals who did not meet the criteria for PTSD but
met the DSM-IV criteria for another anxiety disorder
(i.e., generalized anxiety disorder, social anxiety, obsessive
compulsive disorder, specific phobia, and agoraphobia
without panic disorder) were placed in the other
anxiety group. Individuals who did not meet the criteria
for PTSD or any other anxiety disorder were placed in
the control group.
Self-report questionnaires
The severity of PTSD was assessed with the Posttraumatic
Stress Disorder Checklist (PCL). The PCL is a widely used
instrument with 17 items designed to assess the extent of
overall PTSD symptoms by calculating the sum of all 17
items. Higher scores indicate greater overall PTSD symp-
tom severity. The instrument is highly reliable, with good
convergent validity [24]. Internal consistency in our sam-
ple was high (Cronbach’s alpha =0.99).
The severity of anxiety symptoms related to generalized
anxiety disorder (GAD) was assessed with the GAD-7, a
7-item self-report measure designed for use in primary
care settings where the mean of all 7 items was calculated
[25]. Higher scores indicate greater severity of GAD symp-
toms. The instrument is a highly reliable measure with
strong convergent validity [26]. High internal consistency
was established in our sample (Cronbach’s alpha =0.98).
Symptoms of depression were assessed using the Pa-
tient Health Questionnaire (PHQ), a widely used 9-itemself-report instrument that evaluates the presence of de-
pression symptoms in the past 2 weeks [27]. Higher sum
scores indicate greater depression symptoms. This scale
is highly reliable and has good convergent validity [28],
with high internal consistency in our sample (Cronbach’s
alpha =0.96).
General health status was determined by the widely used
Short-Form Health Survey (SF-36) [29]. This is a 36-item
self-report measure consisting of eight subscales: physical
functioning, physical role limitations, emotional role limi-
tations, mental health, general health, bodily pain, social
functioning, and vitality. Raw scores were standardized
with higher scores indicating better functioning. The
SF-36 is a highly reliable measure with acceptable conver-
gent validity [29]. High internal consistency was established
in our sample (Cronbach’s alpha ranging from 0.86 to 0.94).
Cold pressor task
Cold pain ratings and time to threshold and tolerance
were assessed by the well-validated and widely used cold
pressor test in which one side of a container was filled
with water that was kept at approximately 1–2°C through
the use of ice cubes and a submerged pump in the other
side of the container [30]. Participants were asked to place
their non-dominant hand and forearm in the water com-
partment and to indicate when the sensation changed
from cold to pain (threshold) and when the participant
could no longer stand the pain (tolerance), upon which
they could withdraw their arm from the water. Instruc-
tions prior to the task informed participants that they
would not keep their arm in the water for longer than
5 min. Participants were instructed to rate their current
level of pain intensity and unpleasantness immediately
prior to immersing their hand in the water (baseline), at
threshold, and at tolerance. The pain intensity and unpleas-
antness ratings were determined with the Gracely Box Scale
which is composed of two separate 21-box numerical de-
scriptor scales: the sensory scale, which assesses pain inten-
sity, and the affective scale, which assesses unpleasantness.
Ratings range from 0 (no pain/neutral pleasantness) to 20
(extremely intense pain/very intolerable). The Gracely Box
Scales for intensity and unpleasantness were displayed on
two separate large posters in the exam room for partici-
pants to use as a reference for their ratings. The Gracely
Box Scale has been used in both clinical and healthy popu-
lations [31,32] and has high reliability and construct validity
[33]. The cold pressor protocol was administered by female
research staff blind to participant group status.
We examined the linear trajectory of pain ratings from
baseline to threshold and tolerance as the perceptual in-
dicator of pain sensitivity. This approach accounts for base-
line levels of current pain and unpleasantness ratings prior
to the start of the cold pressor task in which a steeper linear
trajectory across the cold pressor task would suggest higher
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antness ratings at threshold and tolerance relative to baseline
rating), while a blunted linear trajectory would suggest lower
cold pain sensitivity (i.e., lower evoked pain and unpleasant-
ness ratings at threshold and tolerance relative to baseline
rating). Time in seconds from submersion to threshold and
to tolerance was measured using a stopwatch. Because the
feeling of pain does not begin immediately upon submer-
gence, the difference in time from threshold to tolerance was
used as the behavioral indicator of pain sensitivity [34,35].
Statistical analyses
Data were analyzed using Statistical Package for Social
Sciences (SPSS) 16.0 software (IBM, Inc.). An initial set
of analyses compared demographic and clinical charac-
teristics according to group status, using one-way ana-
lysis of variance (ANOVA) with post hoc contrasts for
continuous measures and the chi-square test for the in-
dependence of measures for categorical variables. Given
our small sample size and the exploratory nature of this
study, we determined that correction for multiple compar-
isons would more likely create a large inflation of type II
error and would be an overly conservative approach. One-
way ANOVAs were used to compare differences on the
cold pressor variables according to gender, veteran status,
place of recruitment (clinic versus community), and birth
control and pain medication usage. We also examined the
Pearson product- moment correlation coefficients among
pain and unpleasantness rating variables and the time var-
iables to decide if any of the time variables should be used
as covariates in the main study analyses. We then con-
ducted a mixed-design ANOVA with group (three levels:
control, anxiety, PTSD) as the between-subjects factor,
time point (three levels: baseline, threshold, and tolerance)
as the within-subjects factor, and pain and unpleasant-
ness ratings as the response variables, with post hoc
contrasts to evaluate group differences. Finally, we used
Cox proportional-hazard regression to determine if time
from threshold to tolerance differed according to group
status. Cox proportional-hazard regression is the appro-
priate analytic strategy because the time from threshold to
tolerance was not normally distributed since individuals
kept their arms in the cold pressor for 5 min and therefore
never reached their “true” level of tolerance. Resulting
hazard ratios examined the rate for reaching pain toler-
ance from threshold in the PTSD group compared with
the other anxiety and control groups. The level of stat-
istical significance was set at p <0.05.
Results
Participant characteristics
Of the 61 participants who met all of the study criteria, 16
had a primary DSM-IV diagnosis of PTSD; 12 met the
DSM-IV criteria for any anxiety disorder other than PTSD(i.e., 42% generalized anxiety disorder, 25% social anxiety,
33% obsessive compulsive disorder, 25% specific phobia,
8% agoraphobia without panic disorder), and 33 did not
have PTSD or another anxiety disorder and were included
as controls. Of individuals diagnosed with PTSD, 69% also
met the criteria for another anxiety disorder (i.e., 38% gen-
eralized anxiety disorder, 31% obsessive compulsive dis-
order, 38% social anxiety, 26% specific phobia). Although
these additional diagnoses could likely be ruled out due to
a primary diagnosis of PTSD (American Psychiatric Asso-
ciation, 2000), we are unable to do so given that our diag-
noses were based on a structured interview and not
determined clinically. Only 4 participants (6.3%) were
veterans, 11 (18%) were from a mental health clinic setting,
and the remaining participants were recruited through
flyers and advertisements. In terms of medication usage, 3
participants (4.9%) were taking antidepressant medications,
3 (4.9%) were using other psychotropic medications, 5
(8.2%) were taking pain medication, 2 (3.3%) were taking
birth control pills, and 14 (23%) were taking medication
for other conditions such as hypothyroidism and allergies.
For the 16 individuals included in the PTSD group, the
following trauma types were reported as the most dis-
tressing by the participants: 1 (6.3%) had combat-related
trauma, 1 (6.3%) witnessed someone being badly injured
or killed, 1 (6.3%) experienced rape, 3 (18.8%) experienced
sexual molestation, 5 (31.3%) experienced serious physical
attack or assault, 3 (18.8%) experienced torture or terror-
ism, and 2 (12.5%) were threatened by a weapon or held
captive. Of these trauma types, the one instance of having
witnessed someone being badly injured or killed, all in-
stances of sexual molestation, and one of the instances of
serious physical attack or assault were all reported to have
occurred before the age of 18 years.
Table 1 presents the demographic characteristics of the
entire sample and by group status. Participants were on
average 41 years old (SD =13 years); approximately 49%
were male, and 62% were White. The PTSD and other anx-
iety disorder groups had significantly lower rates of a col-
lege degree than the control group. There were no other
group differences on demographic characteristics.
Clinical characteristics
Table 2 presents findings on self-reported clinical char-
acteristics by group status. There were greater PTSD symp-
toms, anxiety symptoms, and symptoms of depression in
both the PTSD and other anxiety groups compared to the
control group (p <0.05 for all measures). As expected,
symptoms of PTSD were also significantly higher in the
PTSD group compared to the anxiety group (p <0.05).
Individuals in the PTSD and other anxiety disorders groups
exhibited poorer health functioning across all subscales
of the SF-36 compared to the control group (p <0.05). In
addition, the PTSD group exhibited significantly poorer
Table 1 Demographic characteristics of all participants
and by group status
All PTSD Anxiety Control
N = 61 N = 16 N = 12 N = 33
Age, mean (SD) 41 (13) 43 (12) 43 (14) 39 (14)
Male, % 49 47 42 49
Marital status, %
Single, never married 54 50 58 55
Married/living with partner 20 6 25 24
Divorced/separated/widowed 26 44 17 21
Race, %
American Indian or Alaskan
Native
0 0 0 0
Asian 5 0 0 9
Black or African American 18 25 33 9
Native Hawaiian or Pacific
Islander
3 0 0 6
White 62 63 58 64
Other/none reported 12 12 9 12
Hispanic/Latino, % 16 31 17 9
Education, %*
11th grade or less/not reported 5 13 0 3
12th grade/high school grad or
equivalent
13 19 33 3
Some college/technical or
vocation grad
38 56 51 24
Bachelor’s degree or higher 44 12 16 70
*p < 0.05.
Table 2 Clinical characteristics by group status
PTSD
N = 16
Mean (SD)
PTSD Checklist 54 (18.5)*†
Generalized Anxiety Disorder Scale 1.8 (0.8)†
Patient Health Questionnaire 15.1 (7.3)†
Short Form Health Survey
Physical functioning 79.4 (22.6)†
Role physical 57.8 (46.3)*†
Bodily pain 64.3 (24.5)†
General health 60.4 (22.7)†
Vitality 42.2 (21.1)†
Social functioning 53.9 (29.8)†
Role emotional 37.5 (43.7)†
Mental health 50.0 (18.1)†
*p < 0.05 between PTSD and anxiety participants; †p < 0.05 between PTSD and cont
posttraumatic stress disorder; SD: standard deviation.
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anxiety disorders group (p <0.05).Cold pressor outcomes
There were no significant differences on any of the cold
pressor outcomes according to gender (p =0.444–0.968),
veteran status (p =0.458–0.812), place of recruitment
(p =0.159–0.985), and birth control (p =0.393–0.869) or
pain medication usage (p = .061–0.808). Therefore, data
from all participants were analyzed together and the above
factors were not used as covariates. However, 2 participants
were excluded from the analyses due to faulty equipment
at the time of evoked pain testing.
Table 3 presents the raw pain and unpleasantness rat-
ings at baseline, threshold, and tolerance and the average
times (in seconds) to threshold and tolerance as well as
the time from threshold to tolerance by group status.
The correlation coefficients for the association between
the rating and time variables were not significant; there-
fore, the time variables were not used as covariates in
the mixed-designed ANOVA to examine the trajectory of
pain ratings by group status. The mixed-design ANOVA
with group (three levels: control, anxiety, PTSD) as the
between-subjects factor, time point (three levels: baseline,
threshold, and tolerance) as the within-subjects factor, and
pain ratings as a response variable found a significant
omnibus group by time point interaction (Wilks’ Lambda
F (4, 110) =3.078, p =0.019, η2p ¼ 0:101). To follow up
on this significant omnibus interaction, two contrasts were
performed and found to be significant. The linear trajec-
tory across time points differed between PTSD and con-
trol groups (F (1, 45) =11.20, p =0.002, η2p ¼ 0:199) andAnxiety Control p value
(overall F test)N = 12 N = 33
Mean (SD) Mean (SD)
42.1 (19.5)*Δ 20.8 (8.0)†Δ <0.00
1.8 (1.1)Δ 0.1 (0.3)†Δ <0.00
13.8 (9.4)Δ 1.2 (2.0)†Δ <0.00
80.8 (24.9)Δ 95.5 (11.9)†Δ 0.01
81.3 (30.4)* 94.7 (15.0)† 0.001
68.5 (21.1)Δ 87.8 (14.2)†Δ <0.00
58.8 (19.6)Δ 82.7 (14.0)†Δ <0.00
40.8 (23.8)Δ 73.3 (11.1)†Δ <0.00
51.0 (33.1)Δ 97.7 (7.9)†Δ <0.00
38.9 (44.6)Δ 94.9 (18.9)†Δ <0.00
41.0 (23.4)Δ 86.2 (9.4)†Δ <0.00
rol participants; Δp < 0.05 between anxiety and control participants; PTSD:
Table 3 Pain and unpleasantness ratings and time to
threshold and tolerance by group status
PTSD Anxiety Control
N = 15a N = 12 N = 32a
Mean (SD) Mean (SD) Mean (SD)
Pain ratings
Baseline 4.33 (4.63) 1.58 (3.29) .03 (0.18)
Threshold 11.2 (4.13) 13.4 (3.23) 11.2 (4.0)
Tolerance 15.6 (3.29) 17.1 (2.11) 15.7 (0.56)
Unpleasantness ratings
Baseline 3.2 (3.74) 4.17 (4.13) .44 (1.21)
Threshold 10.0 (4.05) 12.2 (3.53) 10.4 (3.23)
Tolerance 15.0 (3.54) 15.7 (2.50) 15.2 (3.50)
Time in seconds
Time to threshold 19.3 (16.8) 26.3 (53.0) 28.6 (47.5)
Time to tolerance 97.0 (116.3) 50.5 (81.3) 66.8 (78.4)
Time from threshold
to tolerance
77.7 (104.8) 24.3 (28.6) 38.1 (48.1)
aData from 2 participants (one in the PTSD group and one in control group)
are not included due to faulty equipment at the time of testing.
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p =0.038, η2p ¼ 0:162). Figure 1 presents the linear trend
of reported pain ratings across time points for each group.
We then examined unpleasantness ratings and the omni-
bus group by time interaction was not significant (Wilks’
Lambda F (4, 110) =1.885, p =0.118, η2p ¼ 0:064).
Cox regressions that examined the hazard ratio trajec-
tories for the behavioral pain sensitivity indicator of time
to tolerance from threshold by group status were not
significant. However, there was a trend (p =0.1) that0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
Baseline Threshold Tolerance
Pa
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 ra
tin
g
anxiety
control
PTSD
Figure 1 The linear trajectory of pain ratings in response to
cold pressor task across time point by group status.PTSD participants took 2 times longer in reaching toler-
ance from threshold compared to individuals in the other
anxiety group (95% confidence interval =0.84 to 4.6) and
1.3 times longer than individuals in the control group
(95% confidence interval =0.6 to 2.6). Although not statis-
tically significant, individuals in the other anxiety group
were 1.5 times faster in reaching tolerance from threshold
compared to those in the control group (95% confidence
interval =0.8 to 3.1).
Discussion
This preliminary study is one of a handful to examine
pain sensitivity in individuals with PTSD, other anxiety
disorders, and healthy controls. Using a cold pressor task,
we found that individuals with PTSD exhibited a signifi-
cantly flatter linear trajectory of cold pain ratings over time
compared to individuals with other anxiety disorders and
control individuals. In addition, individuals with PTSD had
a longer cold pain response time to tolerance compared to
those with other anxiety disorders, although this difference
only approached significance likely due to reduced power.
With the exception of PTSD symptoms, individuals with
PTSD and other anxiety disorders did not differ on any of
the measures of clinical characteristics, and general health
functioning, but were significantly worse than individuals
in the control group. Finally, there were no differences in
any of the cold pressor outcomes based on gender, veteran
status, place of recruitment, and birth control or pain
medication status. Therefore, our findings suggest that
these clinical and demographic characteristics likely may
not account for the pattern of findings between PTSD and
other anxiety disorders in our sample. Taken together, the
flatter trajectory of pain ratings and greater duration from
threshold to tolerance of PTSD participants compared to
the other groups suggest possibly lower cold pain sensitiv-
ity for these individuals using both perceptual and behav-
ioral indicators of pain sensitivity.
Similar to previous findings [6,9,36], individuals with
PTSD and other anxiety disorders had more severe clinical
symptoms across a range of domains including psychiatric
symptoms and physical health functioning. Although not a
clinical measure of pain, higher baseline pain ratings were
reported in individuals with PTSD compared to the other
groups, even after specifically excluding individuals who
would meet the criteria for a chronic pain diagnosis. These
findings are somewhat consistent with previous studies
documenting the co-occurrence of PTSD and chronic pain
[4,5]. Also consistent with previous research, we found that
individuals with PTSD took longer to respond to painful
stimuli compared to individuals with other anxiety disor-
ders [18]. However, our findings on perceptual indicators
of pain sensitivity are different from the one study which
found that individuals with PTSD and chronic pain re-
ported more intense evoked pain ratings compared to
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[18], but are consistent with others which found that indi-
viduals with PTSD alone reported lower pain ratings com-
pared to healthy individuals after accounting for baseline
level of pain [15,16,37,38]. The discrepant findings could
be due to previous study’s inclusion of individuals with
chronic pain who may be more perceptually sensitive to
experimental pain stimuli. Our findings add to the litera-
ture by suggesting individuals with PTSD who do not
report any chronic pain may have lower pain sensitivity
to evoked stimuli even if they report greater baseline pain
compared to individuals with other anxiety disorders.
Our findings are also interesting in light of the existing
literature documenting increased pain sensitivity in those
with chronic pain conditions [10,11], suggesting that there
may be different psychological, biological, and physiological
mechanisms underlying the processing of painful stimuli in
PTSD and chronic pain. In order to examine what is likely
a complex set of associations, our study was a preliminary
step to determine the level of pain sensitivity in individuals
with PTSD only. It would not have been possible to con-
clude if the findings on evoked pain were due to PTSD or
due to chronic pain without excluding participants who
also had chronic pain. These findings can inform future re-
search to examine the additive influence of chronic pain
on pain sensitivity in individuals with PTSD, and the expla-
nations for why the expression of pain sensitivity may po-
tentially differ across PTSD alone and PTSD with chronic
pain. These findings may also potentially shed light on a
subtype of PTSD which is free of chronic pain.
Defrin et al. (2008) [18] suggest two plausible mecha-
nisms to explain evoked pain sensitivity alterations in
PTSD. In terms of sensory processing of painful stimuli,
altered brain processing has been found in individuals
with PTSD [15,17,37] suggesting that lowered pain sensitiv-
ity in individuals with PTSD could be related to altered
brain processes that are also related to avoidance. Individ-
uals with PTSD and those with various pain conditions
also have been reported to exhibit basal diminished
hypothalamic-pituitary-adrenal (HPA) axis response [39]
as well as diminished response to a cold pressor test com-
pared to individuals in a control group [40]. Together,
these findings suggest that altered brain processes and
dysregulation in HPA axis activity may play a role in the
differing sensory processing of pain stimuli in individuals
with PTSD compared to other groups.
In terms of the role of emotional experiences in pain
processing, several factors related to the emotional experi-
ence of PTSD may also influence differential processing
of painful stimuli. Individuals with PTSD not only have
higher rates of chronic pain [1-3,5,8,37,41] but also exhibit
higher anxiety sensitivity [41] and fear of pain [42], which
may impact the processing of their traumatic experiences
as well as the experience of pain. One potential explanationis that those with PTSD may experience dissociation, in-
volving disruption in body awareness and a detachment
from the emotional content of a traumatic experience [43]
that may also numb these individuals to physical pain [44].
Future studies should examine what role dissociative and
numbing symptoms play in the reduced pain sensitivity
seen in individuals with PTSD. Given that similar psycho-
logical factors such as fear of pain and pain catastrophizing
are related to an increase in pain intensity [45] and emo-
tional distress [46], future research also can examine the
role of these and other psychological constructs in the rela-
tionship between PTSD and evoked pain sensitivity. Also,
there is documented comorbidity of PTSD and depression
[47,48] and a mediational role of depression in the relation-
ship between PTSD and pain symptoms [49] that suggest
depression as another factor to consider in studies of
evoked pain sensitivity with PTSD and chronic pain.
Further clarification of this relationship may ultimately
shed light on the role of pain sensitivity in the develop-
ment and maintenance of co-occurring PTSD and chronic
pain conditions.
One of the caveats of the present study (and other stud-
ies) is that it is impossible to determine the direction of
the relationship between evoked pain sensitivity and PTSD
or other anxiety disorders. Although lowered pain sensitiv-
ity may be an outcome, it might also be a risk factor for
the development of PTSD. Given the accumulating find-
ings on lowered evoked pain sensitivity in PTSD, there is a
need for future research to examine the role of pain sensi-
tivity itself in the development of co-occurring PTSD and
chronic pain, as the relationships may be complex. One
model that addresses the potential underlying relation-
ships between these problems is the shared vulnerability
model, which proposes that shared individual difference
factors, such as anxiety sensitivity and sympathetic dysreg-
ulation, influence the development of these disorders [3].
The mutual maintenance model asserts that physio-
logical, affective, and behavioral components exacer-
bate and maintain symptoms of PTSD and pain [42].The
perpetual avoidance model further asserts dysfunctional
cognitive processing following trauma can lead to an in-
crease in psychological and physiological arousal and there-
fore greater behavioral avoidance that maintains both
PTSD and pain [50]. Further, there is a dearth of research
examining the co-occurrence of pain and other anxiety dis-
orders and a need to better understand this co-occurring
relationship beyond PTSD and pain [51]. Future research
to examine the temporal order of lowered evoked pain
sensitivity in the development of these conditions can
shed some light on their co-occurrence.
PTSD is unique in that it requires the occurrence of a
serious adverse life event prior to symptom development.
PTSD also is characterized by numbing, alienation, and de-
tachment which are generally associated with depression
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pervigilance and reactivity which are similar to other anx-
iety disorders. The symptom characteristic of PTSD and a
growing literature on the distinction between PTSD and
other anxiety disorders [52-55] has led to a substantial
change in the DSM-V, by removing PTSD from the list
of anxiety disorders and placing it within a new group
of disorders entitled “Trauma and Stressor Related Dis-
orders” [52]. Our findings on lowered evoked pain sen-
sitivity in PTSD compared to other anxiety disorders may
also provide potential support for a likely distinction be-
tween trauma-related conditions and anxiety disorders and
also suggest that the mechanisms underlying the process-
ing of painful stimuli in PTSD are likely different from the
mechanisms involved in pain processing in anxiety. Future
studies should further examine whether our findings are
unique to PTSD or are better accounted for by the experi-
ence of a traumatic event.
This study has several limitations. First, we had a rela-
tively small sample size which may have hampered our
ability to detect significant differences in the behavioral
indicator of pain sensitivity, although we were able to
detect significant differences in the perceptual indicators.
Further, we did not conduct a medical record review to
confirm the diagnosis of PTSD, or other anxiety disorders
nor did we examine inter-rater reliability of our PTSD and
anxiety disorder groups. Therefore, our findings should
be replicated with a larger sample of participants with
physician-confirmed diagnoses distinguishing PTSD from
other anxiety disorders and other comorbidities and exam-
ine the inter-rater reliability of these diagnoses. It is im-
portant for future research to examine whether PTSD
exclusively accounts for these differences in pain sensitivity
or whether presence of multiple diagnoses leads to lowered
pain sensitivity. Second, while we did not find any gender,
veteran status, place of recruitment, and birth control or
pain medication usage differences on the evoked pain mea-
sures, given our sample size, future studies should examine
the potential influence of these factors on evoked pain
stimuli in larger samples. A recent review of sex differ-
ences in pain experiences suggests increased pain sensi-
tivity and risk for clinical pain in women compared to
men [56]. Therefore, additional large-scale studies are
needed to examine sex differences in evoked pain sensi-
tivity in PTSD that will consider factors such as the im-
pact of the women’s hormonal cycle, genetic factors, and
pain coping on women’s responses to evoked pain stimuli
as potential explanatory mechanisms of sex differences. In
addition, our sample size precluded us from examining
the potential role of physical impairment on pain sensitiv-
ity in individuals with PTSD and other anxiety disorders.
Third, our assessment of pain sensitivity focused on cold
pain and may not generalize to pain sensitivity in other
domains such as heat or pressure nor to pain sensitivityparadigms like the tender points exam that are able to
localize specific or regional areas of pain. However, our
findings are consistent with previous studies that have ex-
amined heat pain sensitivity [15,16,37]. A fourth issue is
that our anxiety disorders group was heterogeneous; fu-
ture studies should examine whether the relationship be-
tween other anxiety disorders and evoked pain sensitivity
differs by type of anxiety disorder. Fifth, the study proce-
dures were administered by female research staff, which
may have influenced the responses of male participants on
the study assessments. Additionally, participants were told
that they could remove their hand from the cold pressor
task after a time limit, possibly creating an expectancy ef-
fect. Therefore, future studies using the cold pressor task
methodology should address these concerns to minimize
any bias in participant responses or ceiling effects. Finally,
individuals were included in this study by their self-report
that they had not been diagnosed or treated for chronic
pain. However, it is possible that participants may have
been experiencing other conditions in which pain is a fea-
ture that were not reported at the time of the experiment.
Therefore, it is recommended that future studies use
physician-confirmed diagnoses or medical records to con-
firm any chronic or acute pain and other diagnoses. We
consider the present study a first step in examining the re-
lationship between PTSD only and experimental pain sensi-
tivity. Future larger studies should compare pain sensitivity
in those with PTSD, chronic pain, and PTSD comorbid
with chronic pain.Conclusions
In conclusion, our findings suggest that although indi-
viduals with PTSD but without chronic pain report sig-
nificantly more clinical symptoms and issues with health
functioning than controls, when examining both percep-
tual and behavioral indicators of pain sensitivity, they ap-
pear to exhibit lower perceived cold pain sensitivity
compared to individuals in the control group and those
with other anxiety disorders. These findings suggest a need
to further examine mechanisms that may explain the differ-
ing relationship of PTSD and other anxiety disorders with
pain sensitivity and how these findings relate to existing
models of co-occurring PTSD and chronic pain. A greater
understanding of these relationships can better explicate
the development, maintenance, and ultimately treatment of
co-occurring PTSD, anxiety, and chronic pain.Abbreviations
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